KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹236 Cr | ₹225 Cr | ₹187 Cr | ₹154 Cr | ₹116 Cr |
What is the latest Total Non-Current Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹236 Cr |
Mar2023 | ₹225 Cr |
Mar2022 | ₹187 Cr |
Mar2021 | ₹154 Cr |
Mar2020 | ₹116 Cr |
How is Total Non-Current Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹236 Cr | 4.53 | |
Mar2023 | ₹225 Cr | 20.61 | |
Mar2022 | ₹187 Cr | 21.51 | |
Mar2021 | ₹154 Cr | 32.94 | |
Mar2020 | ₹116 Cr | - |
Compare Total Non-Current Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KREBS BIOCHEMICALS & INDUSTRIES | ₹163.8 Cr | 4.4% | -5% | -7.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KREBS BIOCHEMICALS & INDUSTRIES | 4.4% |
-5% |
-7.4% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses